$VINE
Fresh Vine Wine, Inc. Stock $vine

$vine Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086922 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$239.5K	$848.0K	$375.9K
YoY Change	-36.29%	58.32%	-42.12%
Cost Of Revenue	$780.6K	$889.8K	$501.4K
YoY Change	55.7%	47.93%	17.09%
Gross Profit	-$541.2K	-$41.89K	-$125.4K
YoY Change	331.4%	-36.5%	-156.7%
Gross Profit Margin	-225.97%	-4.94%	-33.37%
Selling, General & Admin	$1.511M	$1.141M	$3.682M
YoY Change	-58.96%	-52.45%	75.94%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$1.511M	$1.141M	$3.682M
YoY Change	-58.96%	-52.45%	75.94%
Operating Profit	-$2.052M	-$2.130M	-$3.807M
YoY Change	-46.09%	-17.19%	103.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$89.33K	$9.690K
YoY Change	-100.0%	658.15%	3776.0%
Pretax Income	-$2.052M	-$2.130M	-$3.797M
YoY Change	-45.96%	-16.81%	102.96%
Income Tax
% Of Pretax Income
Net Earnings	-$2.094M	-$2.130M	-$3.797M
YoY Change	-44.85%	-16.81%	102.96%
Net Earnings / Revenue	-874.44%	-251.15%	-1010.14%
Basic Earnings Per Share		-$0.13
Diluted Earnings Per Share	-$0.13	-$0.13	-$0.30
COMMON SHARES
Basic Shares Outstanding	15.98M shares	15.98M shares	12.73M shares
Diluted Shares Outstanding		15.98M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$236.3K	$760.0K	$2.080M
YoY Change	-88.64%	-77.75%	-87.05%
Cash & Equivalents	$236.0K	$759.9K	$2.080M
Short-Term Investments
Other Short-Term Assets	$142.9K	$673.9K	$1.030M
YoY Change	-86.12%	7.21%	162.15%
Inventory	$337.9K	$742.4K	$3.696M
Prepaid Expenses	$9.871K		$313.0K
Receivables	$172.1K	$430.9K	$259.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$889.3K	$2.607M	$7.908M
YoY Change	-88.75%	-71.55%	-56.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles			$0.00
YoY Change			-100.0%
Long-Term Investments	$500.0K
YoY Change
Other Assets	$0.00	$0.00	$678.2K
YoY Change	-100.0%	-100.0%	-31.58%
Total Long-Term Assets	$500.0K	$0.00	$678.2K
YoY Change	-26.27%	-100.0%	-31.85%
TOTAL ASSETS
Total Short-Term Assets	$889.3K	$2.607M	$7.908M
Total Long-Term Assets	$500.0K	$0.00	$678.2K
Total Assets	$1.389M	$2.607M	$8.586M
YoY Change	-83.82%	-73.99%	-55.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$509.3K	$554.7K	$589.2K
YoY Change	-13.56%	14.21%	41.39%
Accrued Expenses	$810.7K	$665.6K	$422.9K
YoY Change	91.69%	72.87%	98.68%
Deferred Revenue	$3.407K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.219M	$1.532M	$2.973M
YoY Change	-25.36%	-18.58%	36.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.219M	$1.532M	$2.973M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.219M	$1.532M	$2.973M
YoY Change	-25.36%	-18.58%	36.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.50M	-$24.40M	-$15.82M
YoY Change	67.51%	102.94%	2462.54%
Common Stock	$15.98K	$15.98K	$12.73K
YoY Change	25.48%	25.48%	4.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$829.5K	$1.076M	$5.614M
YoY Change
Total Liabilities & Shareholders Equity	$1.389M	$2.607M	$8.586M
YoY Change	-83.82%	-73.99%	-55.4%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$2.094M	-$2.130M	-$3.797M
YoY Change	-44.85%	-16.81%	102.96%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$223.6K	-$366.8K	-$1.267M
YoY Change	-82.35%	-79.77%	-66.47%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$500.0K
YoY Change
Cash From Investing Activities	-$500.0K		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K	750.0K	-68.29K
YoY Change	-392.87%		-100.35%
NET CHANGE
Cash From Operating Activities	-223.6K	-366.8K	-1.267M
Cash From Investing Activities	-500.0K		0.000
Cash From Financing Activities	200.0K	750.0K	-68.29K
Net Change In Cash	-523.6K	383.2K	-1.335M
YoY Change	-60.78%	-121.13%	-108.43%
FREE CASH FLOW
Cash From Operating Activities	-$223.6K	-$366.8K	-$1.267M
Capital Expenditures			$0.00
Free Cash Flow			-$1.267M
YoY Change			-66.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41147
	dei	Entity Registrant Name EntityRegistrantName	Fresh Vine Wine, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3905007
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	766-9463
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11500 Wayzata Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	# 1147
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minnetonka
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55305
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	VINE
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15976227	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	759946	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2080335	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	430911	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	259317	usd
CY2022Q4	vine	Due From Employees Current01 DueFromEmployeesCurrent01	37733	usd
CY2022Q4	vine	Insurance Recovery Receivable InsuranceRecoveryReceivable	804907	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	742394	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3696198	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	68286	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	573939	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	961211	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2607190	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7907987	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	678167	usd
CY2023Q3	us-gaap	Assets Assets	2607190	usd
CY2022Q4	us-gaap	Assets Assets	8586154	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	554712	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	589204	usd
CY2022Q4	vine	Accrued Compensation AccruedCompensation	420413	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1250000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	665567	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	422931	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2027	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1531639	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2972548	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1531639	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2972548	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	8	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15976227	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15976227	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12732257	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12732257	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15976	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12732	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25457806	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21420732	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24398239	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15819858	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1075551	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5613606	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2607190	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8586154	usd
CY2023Q3	us-gaap	Revenues Revenues	847959	usd
CY2022Q3	us-gaap	Revenues Revenues	535584	usd
	us-gaap	Revenues Revenues	1586714	usd
	us-gaap	Revenues Revenues	2484086	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	889844	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	601546	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3631491	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2049650	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-41885	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-65962	usd
	us-gaap	Gross Profit GrossProfit	-2044777	usd
	us-gaap	Gross Profit GrossProfit	434436	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1141390	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2400182	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4784535	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9155448	usd
CY2023Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	946415	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	105679	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1734765	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2705901	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2129690	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2571823	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8564077	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11426913	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11783	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1296	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21740	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2129660	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2560040	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8562781	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11405173	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15600	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15600	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2145260	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2560040	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8578381	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11405173	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12732244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15085911	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12524132	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12732244	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15085911	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12524132	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17075990	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1824334	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4286243	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14614081	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	619390	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4558890	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10674581	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27430	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2560040	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8141971	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5613606	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2546728	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	257672	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2010824	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6407182	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	374178	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4422297	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2359063	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	750000	usd
CY2023Q3	vine	Preferred Stock Series A PreferredStockSeriesA	12
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	15600	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	111748	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2129660	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1075551	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8562781	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11405173	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3990	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1734765	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2705904	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1732500	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37733	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	171594	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	215228	usd
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-804907	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-51984	usd
	vine	Increase Decreasein Receivables With Recourse increaseDecreaseinReceivablesWithRecourse	-146314	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-269450	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1221304	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3771586	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-74272	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	138773	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-34492	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	68999	usd
	vine	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	-420413	usd
	vine	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	139186	usd
	vine	Increase Decreasein Accrued Expenses Settlement IncreaseDecreaseinAccruedExpensesSettlement	-1250000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	227036	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	172142	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	29333	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-204617	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7973	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4579	usd
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	-88727	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4585403	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12261556	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	216000	usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-171069	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	750000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	2615014	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3365014	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-387069	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1220389	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12648625	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2080335	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16063941	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	859946	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3415316	usd
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	15600	usd
CY2023Q3	us-gaap	Cash Cash	100000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Accounting Estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management uses estimates and assumptions in preparing these financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include contingent liabilities, allowance for doubtful accounts, inventory allowances, equity-based compensation for employees and non-employees, and the valuation of deferred tax assets.</p>
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	4000000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	2400000	usd
CY2023Q3	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	24400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12300000	usd
CY2023Q3	vine	Working Capital WorkingCapital	1100000	usd
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	760000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	100000	usd
	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	800000	usd
CY2023Q3	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
CY2023Q3	vine	Revenue Percentage RevenuePercentage	1	pure
CY2022Q3	vine	Revenue Percentage RevenuePercentage	1	pure
	vine	Revenue Percentage RevenuePercentage	1	pure
	vine	Revenue Percentage RevenuePercentage	1	pure
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2129660	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2560040	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8562781	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11405173	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15600	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15600	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2145260	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2560040	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8578381	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11405173	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12732244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15085911	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12524132	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12732244	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15085911	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12524132	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
	us-gaap	Weighted Average Numer Diluted Limited Partnership Units Outstanding Adjustment WeightedAverageNumerDilutedLimitedPartnershipUnitsOutstandingAdjustment	5905528	shares
	us-gaap	Weighted Average Numer Diluted Limited Partnership Units Outstanding Adjustment WeightedAverageNumerDilutedLimitedPartnershipUnitsOutstandingAdjustment	1691562	shares
	us-gaap	Inventory Write Down InventoryWriteDown	1700000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	209000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	742394	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3683159	usd
CY2022Q4	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise	13039	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	742394	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3696198	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	313000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	678167	usd
CY2023Q3	vine	Inventory Deposits InventoryDeposits	293824	usd
CY2022Q4	vine	Inventory Deposits InventoryDeposits	569377	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	196959	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	83156	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	78834	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	573939	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1639378	usd
CY2023Q3	vine	Sponsorship Agreement SponsorshipAgreement	499488	usd
CY2022Q4	vine	Sponsorship Agreement SponsorshipAgreement	234494	usd
CY2023Q3	vine	Accrued Credit Card Charge AccruedCreditCardCharge	2774	usd
CY2022Q4	vine	Accrued Credit Card Charge AccruedCreditCardCharge	21013	usd
CY2023Q3	vine	General Trade Payable Accrual GeneralTradePayableAccrual	136869	usd
CY2022Q4	vine	General Trade Payable Accrual GeneralTradePayableAccrual	107424	usd
	vine	Preferred Cumulative Dividends PreferredCumulativeDividends	15600	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10836	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	60000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	665567	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	422931	usd
CY2023Q3	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	88331	usd
	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	264993	usd
CY2022Q3	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	142000	usd
	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	224000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Subscribed But Unissued TemporaryEquitySharesSubscribedButUnissued	6366129	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
CY2023Q1	us-gaap	Financial Instrument Subject To Mandatory Redemption Par Value Per Share FinancialInstrumentSubjectToMandatoryRedemptionParValuePerShare	0.5
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023Q1	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	3140000	usd
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	2600000	usd
	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	3930000	usd
CY2023Q3	vine	Aggregate Share Purchase AggregateSharePurchase	10000	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	4000	shares
CY2023Q3	vine	Aggregate Purchase Price AggregatePurchasePrice	400000	usd
CY2023Q3	us-gaap	Shares Issued SharesIssued	4000	shares
CY2023Q3	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.05
	vine	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.199	pure
	vine	Capital Or Surplus Of Percentage CapitalOrSurplusOfPercentage	1.50	pure
	vine	Stock Issued And Outstanding StockIssuedAndOutstanding	0.50	pure
	vine	Per Share Percentage PerSharePercentage	2	pure
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.12	pure
	us-gaap	Investment Company Purchase Premium Per Share InvestmentCompanyPurchasePremiumPerShare	0.47
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	15600	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	15600	usd
CY2023Q2	vine	Equity Based Compensation Expense EquityBasedCompensationExpense	834668	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	834668	shares
	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	0	usd
	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.75	pure
CY2023Q3	vine	Accrued Compensation AccruedCompensation		usd
	vine	Purchases Finished Goods PurchasesFinishedGoods	0.20	pure
CY2023Q3	vine	Percentage Of Wholesale Revenue PercentageOfWholesaleRevenue	0.96	pure
	vine	Percentage Of Wholesale Revenue PercentageOfWholesaleRevenue	0.87	pure
CY2022Q3	vine	Percentage Of Wholesale Revenue PercentageOfWholesaleRevenue	0.68	pure
	vine	Percentage Of Wholesale Revenue PercentageOfWholesaleRevenue	0.70	pure
CY2023Q3	vine	Percentage Of Customers Accounted PercentageOfCustomersAccounted	0.91	pure
CY2022Q4	vine	Percentage Of Customers Accounted PercentageOfCustomersAccounted	0.90	pure
	vine	Investor Options To Terminate Agreements InvestorOptionsToTerminateAgreements	2000000	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	89333	usd
	us-gaap	Other Expenses OtherExpenses	329333	usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses	120000	usd
	us-gaap	Other Expenses OtherExpenses	260000	usd
	us-gaap	Legal Fees LegalFees	1250000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	805000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	400000	usd
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	250000	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	500000	shares
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q3	vine	Due From Employees Current01 DueFromEmployeesCurrent01		usd
CY2023Q3	vine	Insurance Recovery Receivable InsuranceRecoveryReceivable		usd
CY2023Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross		usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	vine	Increase Decreasein Receivables With Recourse increaseDecreaseinReceivablesWithRecourse		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	vine	Increase Decreasein Accrued Expenses Settlement IncreaseDecreaseinAccruedExpensesSettlement		usd
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q3	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise		usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance		usd
CY2022	vine	Preferred Cumulative Dividends PreferredCumulativeDividends		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001880343

Files In Submission

Name	View Source	Status
vine-20230930_cal.xml	Edgar Link	unprocessable
0001213900-23-086922-index-headers.html	Edgar Link	pending
0001213900-23-086922-index.html	Edgar Link	pending
0001213900-23-086922.txt	Edgar Link	pending
0001213900-23-086922-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_freshvine.htm	Edgar Link	pending
f10q0923ex31-2_freshvine.htm	Edgar Link	pending
f10q0923ex32-1_freshvine.htm	Edgar Link	pending
f10q0923_freshvine.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_freshvine_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vine-20230930.xsd	Edgar Link	pending
vine-20230930_def.xml	Edgar Link	unprocessable
vine-20230930_lab.xml	Edgar Link	unprocessable
vine-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VINE
Fresh Vine Wine, Inc. Stock $vine

2023 Q4 Form 10-Q Financial Statement

#000121390023086922 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE Fresh Vine Wine, Inc. Stock $vine

2023 Q4 Form 10-Q Financial Statement

#000121390023086922 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE
Fresh Vine Wine, Inc. Stock $vine